Search Results

The diabetes drugs market size valued at USD 66 billion in 2023 is projected to grow at a CAGR of 6.7% from 2023 to 2032, reaching an estimated value of USD 118 billion by 2032.

The global pharmacogenomics market size was reached at USD 15 billion in 2022 and is forecasted to be worth over USD 35.67 billion by 2032 with a CAGR of 9.1% from 2023 to 2032.

Global DNA Nanotechnology Market is valued at US$ 4.34 Bn in 2023, and it is expected to reach US$ 24.29 Bn by 2031, with a CAGR of 24.67% during the forecast period of 2024-2031.

The global cell therapy market size was valued at USD 4.85 billion in 2023 and is projected to surpass around USD 37.42 billion by 2033, registering a CAGR of 22.67% over the forecast period of 2024 to 2033 according to Nova One Advisor.

CervoMed Inc. today announced that Company’s Management will provide a corporate update at the Emerging Growth Conference 67, to be held virtually from February 7-8, 2024.

The global U.S. cell therapy market size was valued at USD 2.88 billion in 2023 and is poised to grow from USD 3.49 billion in 2024 to USD 19.67 billion by 2033, growing at a CAGR of 21.18% in the forecast period (2024-2033).

NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the signing of a Clinical Supply Agreement with Clarity Pharmaceuticals for the production of 67Cu-SAR-bisPSMA drug product for Clarity’s Phase I/II and Phase III trials.

AAPS Salary Survey Shows 6.7% Compensation Increase Since 2022